ASLAN Pharmaceuticals Accounts Payable

ASLAN Pharmaceuticals (ASLN) currently reports a accounts payable of $9.7M as of March 2024. That compares with $10M in the prior-year period — down 3.6% year over year. Use the charts on this page to explore ASLAN Pharmaceuticals's accounts payable history and peer comparisons.

ASLAN Pharmaceuticals's accounts payable decreased from $10M to $9.7M — a 3.6% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ASLAN Pharmaceuticals reported $9.7M in accounts payable as of March 2024. That compares with $10M in the prior-year period — down 3.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $9.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ASLAN Pharmaceuticals, and consider following ASLN for alerts when major investors trade the stock.

ASLAN Pharmaceuticals is classified in the Healthcare sector. On accounts payable, it currently shows $9.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ASLN with unrelated industries.